Anaxago

What is Anaxago?

Anaxago is an investment fund based in Paris, specializing in crowdfunding strategies for real estate and startups. They operate with a minimum investment of 500,000 euros and a maximum of 3,000,000 euros, focusing primarily on Seed, Series A, and Series B stages. Anaxago targets companies in the Healthcare (both Medtech and Biotech, though Biotech is not constrained by MRR requirements), Proptech, and Fintech sectors that have a minimum Monthly Recurring Revenue (MRR) of 40k euros.

Established in 2012, Anaxago has played a pivotal role in empowering over 15,000 investors to diversify their financial portfolios, providing simplified access to unique and committed investment opportunities. With over 850 million euros invested, they have financed more than 350 projects in real estate and venture capital, fostering the growth of tomorrow's world.

Anaxago's average real estate performance is noted at 9.7%, leveraging advantageous tax arrangements such as PEA & PEA/PME and IR reduction. Their diverse portfolio includes active involvement in the real estate, innovation through venture and private equity, and eco-responsibility by investing in decarbonization.

The firm prides itself on transparency and high advisor expertise, offering personalized counsel to investors, helping them achieve their life goals through unique investment opportunities. Anaxago features a team with over ten years of experience in the investment sector, ensuring that the investors have access to exceptional and innovative investment products previously reserved for major institutional investors.

What they say:

We invest in Healthcare (Medtech or Biotech), Proptech and Fintech companies with at least 40k€ MRR (excl. Biotech).